Exits
Asset sale vs share sale: the difference that shapes every UK exit
Whether a buyer purchases your company's shares or just its assets changes who is liable for what, how much tax you pay, and how complicated completion becomes.
By Daily Tech Times ·
Exits The mechanics of structuring an earn-out in a UK acquisition
Scaleups What a Data Room Actually Contains Before a UK Funding Round
Scaleups The Rule of 40: how investors use it to judge a scaleup's health
Across the money desk
The latest in every corner of your finances Funding
- How Venture Debt Works Alongside Equity for UK Scaleups
- What a bridge round is and why startups raise one
- SAFE or priced round? How the two fundraising routes differ for UK founders
- Equity crowdfunding vs venture capital: how UK platforms like Crowdcube and Seedrs actually work
Founders
- How an option pool dilutes founders and why investors want one
- How EMI Share Options Are Taxed for UK Employees
- What a Founder Vesting Schedule and Cliff Actually Protect Against
- Good leaver, bad leaver: what these clauses mean for UK founders
Scaleups
- What a Data Room Actually Contains Before a UK Funding Round
- The Rule of 40: how investors use it to judge a scaleup's health
- What ARR, MRR and net revenue retention actually measure
- Patent basics for UK deep-tech startups
Exits
- Asset sale vs share sale: the difference that shapes every UK exit
- The mechanics of structuring an earn-out in a UK acquisition
- MedPal AI finalises eMARx purchase price at about £446,633, below its July estimate
- What due diligence actually involves when a UK startup gets acquired
AI
- UK AI Growth Zones and compute strategy: what's actually on offer for AI startups
- Spin-outs from UK universities: how research becomes an AI or deep-tech startup
- UK AI startup valuations: why they're running higher and what's actually driving it
- Data and IP ownership in AI startups: what UK founders should get right early